FULC Fulcrum Therapeutics
Fulcrum Therapeutics earnings company data as of 4:45 AM ET 11/1
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | -0.11 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by FULC's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $1.5M bought by 1 insider
- $58.4M sold by 1 insider outside a trading plan
- $600K sold by 3 insiders under 10b5-1 plans
-
Kevin Tang 10% owner, +1 joint filerBuy$595K 167,616 shares at $3.55 +2.4% to stakeTraded Jul 16–17 Filed Jul 20
-
Kevin Tang 10% owner, +1 joint filerBuy$891K 249,946 shares at $3.57 +3.8% to stakeTraded Jul 13–15 Filed Jul 15
-
Alan Ezekowitz DirectorPlanned sale$66K 18,000 shares at $3.65 62% of stakeTraded Jun 26 Filed Jun 30
-
Robert J Gould DirectorPlanned sale$163K 15,000 shares at $10.87 3.1% of stakeTraded Jan 2 Filed Feb 4
-
Robert J Gould DirectorPlanned sale$161K 15,000 shares at $10.72 3.2% of stakeTraded Feb 2 Filed Feb 4
-
Curtis Gale Oltmans Chief Legal OfficerPlanned sale$45K 3,452 shares at $12.92 25% of stakeTraded Dec 15, 2025 Filed Dec 17, 2025
-
Ra Capital Management, L.P. 10% owner, +3 joint filersSale$58.4M 4,175,139 shares at $13.98 41% of stakeTraded Dec 8, 2025 Filed Dec 10, 2025
-
Robert J Gould DirectorPlanned sale$165K 15,000 shares at $11.03 3% of stakeTraded Nov 19, 2025 Filed Nov 21, 2025
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 1.01,3.02,5.01,5.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.05,8.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 1.02,2.02,5.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.